RecruitingPhase 2NCT05253495

Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma

Studying Hodgkin lymphoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
New York Medical College
Principal Investigator
Mitchell Cairo, MD
New York Medical Center
Intervention
DOC Group B(drug)
Enrollment
80 enrolled
Eligibility
3-39 years · All sexes
Timeline
2022 – 2028

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05253495 on ClinicalTrials.gov

Other trials for Hodgkin lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Hodgkin lymphoma →

← Back to all trials